In a newborn with a temporarily enlarged head circumference, is this a benign physiologic macrocephaly and what is the appropriate management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Benign Head Enlargement in Newborns

In a newborn with temporarily enlarged head circumference, this is most commonly benign familial macrocephaly or benign enlargement of subarachnoid spaces (BESS), both of which are self-limited conditions that require observation rather than intervention.

Understanding the Condition

Macrocephaly is defined as an occipitofrontal circumference (OFC) >2 standard deviations above the mean for age and sex 1, 2. Mild macrocephaly (2-3 SD above mean) with an otherwise structurally normal brain is frequently seen in typically developing children, often representing benign familial macrocephaly 1.

The key distinction is that macrocephaly refers to head size, while megalencephaly refers specifically to brain overgrowth 2. Macrocephaly has multiple benign causes beyond true brain enlargement, including:

  • Benign familial macrocephaly (family members similarly affected)
  • Benign enlargement of subarachnoid spaces (BESS)
  • Increased skull thickness
  • Transient fluid retention in premature infants 3

Clinical Assessment Algorithm

Step 1: Measure and Track Growth Pattern

  • Document serial OFC measurements
  • Plot on growth curves - benign macrocephaly typically shows accelerated early growth that stabilizes around ages 2-3 years 4
  • In BESS specifically, HC rate of change >0.043 cm/day at 5-7 months is 82% specific for the diagnosis 5

Step 2: Obtain Detailed Family History

  • Measure parental head circumferences
  • Ask about similarly affected family members
  • If close family members have large heads and normal development, this strongly suggests benign familial macrocephaly 6

Step 3: Assess for Red Flags Requiring Imaging

Do NOT image if:

  • Normal development for age
  • No neurologic deficits
  • Stable growth velocity
  • Positive family history of macrocephaly
  • No signs of increased intracranial pressure

DO image if any of the following:

  • Developmental delays or regression
  • Abnormal neurologic examination
  • Signs of increased ICP (bulging fontanelle, splaying sutures, vomiting, lethargy, abnormal eye movements) 7
  • Rapidly progressive head growth (crossing percentile lines upward)
  • OFC >3 SD above mean (clinically relevant macrocephaly) 8
  • No family history of macrocephaly

Step 4: Physical Examination Specifics

Look for:

  • Fontanelle tension (should be soft and flat)
  • Suture palpation (progressive splaying suggests pathology) 7
  • Developmental milestones appropriate for corrected age
  • Neurologic examination including tone, reflexes, eye movements
  • Dysmorphic features or skin findings suggesting genetic syndromes 9

Management Approach

For benign macrocephaly (familial or BESS):

  • Reassure parents - no intervention needed 6
  • Serial OFC measurements at well-child visits
  • Monitor developmental milestones
  • No medications indicated
  • No imaging required if clinical criteria met

Common pitfall: Ordering unnecessary neuroimaging in infants with clear familial macrocephaly and normal development. This exposes the infant to sedation risks and increases parental anxiety without clinical benefit 4.

For premature infants: Transient macrocephaly can occur due to sodium and water retention causing brain edema 3. This resolves spontaneously as fluid balance normalizes.

When Conservative Management Fails

If head growth becomes pathologically rapid or neurologic signs develop:

  • Obtain cranial ultrasound (if fontanelle open) or MRI
  • Differentiate true hydrocephalus from benign ventriculomegaly
  • Note that persistent ventriculomegaly alone does not predict poor neurocognitive outcomes 10
  • Surgical intervention only indicated for symptomatic hydrocephalus with signs of increased ICP 7, 11

The critical distinction: Asymptomatic ventriculomegaly or enlarged subarachnoid spaces with normal development can be managed conservatively, while symptomatic hydrocephalus with clinical deterioration requires neurosurgical evaluation 10.

References

Research

Development of Benign Enlargement of Subarachnoid Spaces Growth Charts.

Journal of pediatrics. Clinical practice, 2025

Research

Fifteen-minute consultation on the infant with a large head.

Archives of disease in childhood. Education and practice edition, 2013

Research

Diagnostic Approach to Macrocephaly in Children.

Frontiers in pediatrics, 2021

Research

Macrocephaly is not always due to hydrocephalus.

Journal of child neurology, 1989

Related Questions

How should a newborn with head circumference at or above the 97th percentile be evaluated for macrocephaly?
Who do I refer a 15-month-old child with macrocephaly to?
What is the medical term for macrocephaly (large head)?
In a toddler with frontal bossing and posterior headaches, what is the appropriate urgent evaluation and management?
Which adult occipitofrontal circumference (head circumference) reference chart should be used to determine parental macrocephaly?
Is it feasible to conduct a network meta‑analysis comparing oral ciprofloxacin plus metronidazole plus intravenous prophylactic antibiotics with mechanical bowel preparation versus oral neomycin plus metronidazole plus intravenous prophylactic antibiotics with mechanical bowel preparation on anastomotic leak and surgical‑site infection rates in patients with left‑sided colonic adenocarcinoma undergoing primary surgery?
Does yellow‑green vomit indicate jaundice, and what diagnostic work‑up is recommended?
When is it appropriate to prescribe the ofloxacin (fluoroquinolone) and ornidazole (nitro‑imidazole) combination?
In a patient admitted with an acute illness, should linagliptin be continued, and what criteria (e.g., ability to eat, hemodynamic stability, renal function) determine whether to hold or resume the medication?
Is hematuria in this patient an indication to review apixaban 5 mg twice daily?
When can a patient with a history of inadequately treated latent tuberculosis, no symptoms, normal chest X‑ray, who has been on rifampin 600 mg daily for three days and has completed three sputum collections on a detox unit, be transferred to a residential program?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.